206
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Synthesis and drug loading improvements on mesoporous SBA-15 by spray drying

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1895-1903 | Received 22 Nov 2021, Accepted 01 May 2022, Published online: 15 May 2022
 

Abstract

SBA-15 mesoporous silica is a material used as drug carrier material due to its structural characteristics and biocompatibility. The large surface area of this material improves drug loading and drug release. Typically, SBA-15 is produced by a cooperative self-assembly process under acidic conditions using the triblock copolymers as template and tetraethoxysilane (TEOS) as the silica sources under conventional and batched process. In the last years, spray drying has been proposed to reduce the time to obtain SBA-15 (dry and not calcined) to just seconds, whereas with conventional techniques, this process can take from 6 to 48 h. Additionally, the loading, dissolution, and stability of drugs are improved using co-spray drying (SBA-15 and drugs) due to the pore spatial confinement and avoiding the re-crystallization process of drugs. Furthermore, drug-loaded SBA-15 particles obtained by spray drying have a defined size, high sphericity, and easy handling these characteristics are relevant to its incorporation in dosage forms. Several factors influence the final characteristics of SBA-15 drug-loaded particles, for mention a few: precursors, solvents, time of aging, the temperature of drying, pressure, etc. In this review, the key parameters for the synthesis and loading of drugs on SBA-15 using the spray drying technique are explored and analyzed giving information about how these parameters impact the loading, dissolution, and stability of drugs.

Acknowledgments

The authors acknowledge for the grant 2203800268 from the UAM-X.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

This work was supported by Consejo Nacional de Ciencia y Tecnología (CONACYT-SEP) [Grant CB A1-S-39237].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.